Location History:
- Pittsburgh, PA (US) (2013 - 2017)
- Mt. Pleasant, CA (US) (2017)
- Mt. Pleasant, SC (US) (2018)
- Mt Pleasant, SC (US) (2016 - 2020)
- Mt Pleasant, NC (US) (2024)
Company Filing History:
10 out of 1,866 
4 out of 173 
2 out of 7 
Years Active: 2013-2024
Title: The Innovative Contributions of Carol A. Feghali-Bostwick
Introduction
Carol A. Feghali-Bostwick is a prominent inventor based in Pittsburgh, PA, who has made significant advancements in the field of biotechnology. With a focus on treatments for fibrosis, she holds a total of 12 patents that underscore her commitment to innovation and research.
Latest Patents
Two of her latest patents showcase her pioneering work in the use of endostatin fragments and variants. The first patent describes materials and methods utilizing polypeptides containing fragments and variants of endostatin to treat fibrosis. This breakthrough aims to provide new therapeutic options for managing this condition. The second patent elaborates on producing endostatin fusion polypeptides in plant cells, highlighting methods for generating polypeptides that exhibit anti-fibrotic activity. These fusion polypeptides include an IgG Fc domain along with a section of human endostatin, enabling the formation of high molecular weight multimers.
Career Highlights
Throughout her career, Carol has been affiliated with notable organizations that have provided a platform for her research. She has worked at the University of Pittsburgh - of the Commonwealth System of Higher Education and the MUSC Foundation for Research Development. Her work has significantly contributed to the understanding and potential treatments for fibrosis.
Collaborations
Collaboration has been a key aspect of Carol’s career. She has had the opportunity to work alongside accomplished colleagues, including Yukie Yamaguchi and Pamela Anne Hershberger, fostering an environment of innovation and teamwork in the pursuit of scientific knowledge.
Conclusion
Carol A. Feghali-Bostwick's contributions to the field of biomedical research are invaluable. With her innovative patents and collaborative spirit, she continues to pave the way for future advancements in the treatment of fibrosis. Her work not only exemplifies her dedication to her field but also highlights the importance of research in developing effective therapeutic solutions.